SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.Right who wrote (1070)1/30/1998 7:24:00 PM
From: Harry Ehrlich  Read Replies (2) of 2173
 
I don't know much abpout the medical aspects of Amylin's product. But the chart looks good from a technical point of view. The bottom point we saw a few days ago was a classic bottom. In candlestick terminology it's called a hammer. I know it as a "lizard". It's that classic "t" shaped daily bar. It happened under high volume. This is an indication that the selling pressure has exhausted itself and the buyers are coming in. The confirmation occurred the next day when AMLN continued to rise.

I don't expect anything spectacular in the near term, as AMLN has a long way to go with its program. But I believe the street is always looking to find a fair valuation for a stock. That number should be between 4+ and 8, which are the recent low and high levels. My feeling is that anything bought in the low 5 range will be a good hold for the future, as there may not be too much downside from here. Even if you have to hold for a long time, if the stock settles in at 6 and you bought at 5, there will be no pain in holding. Just my thoughts.

Harry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext